Original language | English (US) |
---|---|
Pages (from-to) | 1861-1863 |
Number of pages | 3 |
Journal | Clinical Neurology and Neurosurgery |
Volume | 115 |
Issue number | 9 |
DOIs | |
State | Published - Sep 2013 |
Funding
This work was funded in part by NIH grant R01 NS 047029 and 074995 and K24 NS060950 to IJK. Igor Koralnik is funded by NIH grants R01 NS 047029 and 074995, and K24 NS 060950, has received a research grant from Biogen Idec and the National Multiple Sclerosis Society. He has served on scientific advisory boards for F. Hoffman-La Roche, Inc., GlaxoSmithKline, and Merck Serono and received consulting fees from Bristol-Myers Squibb, Ono Pharmaceuticals Co. Ltd., Merck Serono, F. Hoffman-La Roch, Inc., GlaxoSmithKline, Perseid Therapeutics, Vertex Pharmaceuticals, Johnson & Johnson. He is an editorial board member for the Journal of NeuroVirology and receives royalties from UpToDate for articles on the management of HIV and CNS mass lesions and on PML.
Keywords
- EBV
- HIV
- IRIS
- JCV
- PML
ASJC Scopus subject areas
- Surgery
- Clinical Neurology